 |
|
|
 |
|
LEADING IN METASTATIC BREAST CANCER TREATMENTSpecialised Therapeutics Pty Ltd (STA) is a privately held, non listed Australian company dedicated to helping Australians fight serious diseases such as stage four breast cancer, pancreatic cancer, lung cancer and melanoma. Founded in 2007, STA’s mission is to in-license and develop unique and specialised drug technologies which deliver superior patient benefits. Our current focus is in cancer, both the treatment and amelioration of side effects associated with many cancer therapies through two world leading therapies ABRAXANE and ALOXI. Read more about these therapies, please click on the product name on this page. |
LATEST NEWS, EVENTS AND MEDIASpecialised Therapeutics’ Compassionate Program has provided cancer patients access to over $1m of cancer drug, ABRAXANE® since TGA approvalHundreds of cancer patients around Australia have had free and subsidised access to a world leading cancer drug, under a compassionate program administered by the family-owned bio-pharmaceutical company which markets the treatment in Australia.Approval granted to market ABRAXANE® in New ZealandMEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing ABRAXANE® for the treatment of metastatic breast cancer.PBS change for leading breast cancer drug ABRAXANE®From 1 July, Abraxane will be available via PBS Authority to patients with ‘Metastatic breast cancer after failure of prior therapy.’STA Compassionate Patient StoryChannel 9 news report of breast cancer drug, Abraxane, used to treat a melanoma patient.STA Compassionate Patient StorySubiaco Medical Oncologist Dr Andrew Dean is featured in this story by Today Tonight. |
|
|